|
|
 |
|
Viewing report
|
|
|
|
North American Cardiovascular Devices Market - Investment Analysis and Growth Opportunities
Frost & Sullivan, May 2006
Frost & Sullivans Medical Devices Financial Benchmarking & Analysis (FBA) service presents a broad financial outline of the medical devices industry, highlighting major market and financial trends in key growth segments. It provides a comprehensive financial analysis of leading medical devices firms to support the investment and financial analysis needs of decision makers in the marketplace. The current study within the service focuses on the following key growth sectors of the North American Cardiovascular Devices Market: cardiac rhythm management, interventional cardiology, and cardiac surgery.
Increased Consolidation and Improved Prospects for Venture Capital Investor
The North American Cardiovascular Devices Industry is characterized by a relatively fewer number of participants that are on an aggressive acquisition spree. With the acquisition of Guidant by Boston Scientific, the space is consolidating further. Moreover, smaller companies that develop technologies catering to an unmet need, or that convert a surgery from an in-patient to an out-patient setting, have historically been the takeover targets by larger companies. Against such backdrop, this study aims to address issues such as: the impact of consolidation on venture capital investments in the industry, the effect of the consolidation on the exit market for venture capitalists, the IPO market as an exit strategy for venture capital investors, and the segments that demonstrate significant growth potential and are attracting increased interest.
Rise in Number of Out-Patient Surgeries Providing Additional Investment Opportunities
There is an increasing preference in the market for minimally invasive surgeries amongst patients as well as doctors. These surgeries are associated with lesser trauma, shorter recovery time, and lesser post operative pain. Cardiologists also stand to gain from this trend, as more surgeries can be performed at a given time.Thus, any technology that could convert a surgery from an in-patient to an outpatient setting is considered to be a good investment and is welcomed by the market.
Benefits of the Servic
- Comprehensive industry mapping of public and private companies
- Growth opportunities for public and private companies
- Comprehensive financial benchmarking
- Fundamental industry data and tracking
- Proprietary industry research on select markets
- Valuation and financial metrics
- Global coverage
- Confidential analyst briefings on research findings
- Unlimited analyst access
- Quarterly and ad-hoc research services
- Workshops, seminars and briefings to supplement the value of the written work
- Ability to provide input on the topics addressed and researched as part of the service
Market Sectors
Frost & Sullivan’s expert analysts thoroughly examine the following sectors in this research:
- Cardiac Rhythm Management
- Interventional Cardiology
- Cardiac Surgery
Whats Included
- North American Cardiovascular Devices market segment revenues
- Industry economics, value chain analysis
- Investment themes
- Growth Monitor for over 30 companies
- Company & Sector Scorecards
- Valuations based on sales, profitability, and financial analysis
- Historical mergers & acquisitions for 5 years
- Private equity & venture capital activity
- Frost & Sullivan Medical Devices Stock Index
|
|
|
|
